FindTrial
Sign In

Efficacy of Visia in evaluating rosacea

Efficacy of Visia in evaluating the severity of rosacea

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200058297
Enrollment
Unknown
Registered
2022-04-04
Start date
2021-05-01
Completion date
Unknown
Last updated
2023-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rosacea

Interventions

case series:None

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients with rosette acne diagnosed by a dermatologist (according to the 2017 NRS rosette Acne Diagnostic criteria); 2. Sign written informed consent.

Exclusion criteria

Exclusion criteria: 1. Ocular rosette acne without facial involvement; 2. Pregnant or lactating patients; 3. Patients with severe mental illness; 4. Systemic diseases (including respiratory, digestive, circulatory, musculoskeletal, immune system diseases).

Design outcomes

Primary

MeasureTime frame
red areas;physician's assessment;—

Countries

China

Contacts

Public ContactJiang Xian

West China Hospital, Sichuan University

jennyxianj@163.com+86 18980601693

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026